21 – 30 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
(
- Contribution to journal › Article
- 2013
-
Mark
Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)
(
- Contribution to journal › Article
-
Mark
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
(
- Contribution to journal › Article
-
Mark
CDK-mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer
(
- Contribution to journal › Article
- 2012
-
Mark
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer
(
- Contribution to journal › Article
- 2009
-
Mark
JAM-A expression positively correlates with poor prognosis in breast cancer patients
(
- Contribution to journal › Article
- 2007
-
Mark
Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
(
- Contribution to journal › Article
-
Mark
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
(
- Contribution to journal › Article
- 2005
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article